Moderna (MRNA) Return on Sales (2017 - 2026)
Moderna (MRNA) posted quarterly Return on Sales of 0.05% for Q2 2026, little changed year-over-year from 0.05% in Q2 2025, and down 56.21% on a QoQ basis from 0.03% in Q1 2026.
Moderna (MRNA) Return on Sales (2017 - 2026) Analysis & Trends
Moderna has reported Return on Sales for 10 years, with the latest figure at 0.05% in Q2 2026.
- Return on Sales for Q2 2026 came in at 0.05%, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
- Return on Sales declined to 0.05% in Q2 2026, from 0.03% in the prior quarter.
- Over five years, Return on Sales peaked at 0.01% in Q1 2022 and troughed at 0.09% in Q1 2025.
- A 5-year average of 0.02% and a median of 0.01% in 2024 frame the typical range for Return on Sales.
- The widest annual swing landed in 2024, when Return on Sales dropped 7 bps; it then climbed 6 bps in 2026.
- A 5-year view of Return on Sales shows it stood at 0.0% in 2022, then plunged by 73 bps to 0.0% in 2023, then plunged by 1602 bps to 0.01% in 2024, then declined by 5 bps to 0.01% in 2025, then sank by 343 bps to 0.05% in 2026.
- Per Business Quant data, the three most recent Return on Sales figures were 0.05% in Q2 2026, 0.03% in Q1 2026, and 0.01% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.00% |
| 10 | Roivant Sciences | 26.27 Bn | 26.27 Bn | 1.16 Mn | -2.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.05% |
| Mar 31, 2026 | -0.03% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | -0.06% |
| Mar 31, 2025 | -0.09% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -0.05% |
| Mar 31, 2024 | -0.07% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.01% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.01% |